News

Filter

Current filters:

Asia-Pacific

1 to 9 of 1497 results

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

08-01-2015

Shares of Japanese mid-size drugmaker Kyowa Hakko Kirin rose 3.55% to 1,138 yen by afternoon trading…

Asia-PacificentinostatJapanKyowa Hakko KirinLicensingOncologyPharmaceuticalSyndax Pharmaceuticals

Asia-Pacific type 2 diabetes market to hit $10.5 billion by 2020

06-01-2015

The type 2 diabetes treatment market in Asia-Pacific (APAC) region will rise in value from an estimated…

Asia-PacificChinaDiabetesIndiaMarkets & MarketingmetforminPharmaceutical

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

24-12-2014

US specialty pharma firm Ariad Pharmaceuticals has entered into an agreement for Japan’s Otsuka Pharmaceuticals…

Ariad PharmaceuticalsAsia-PacificBiotechnologyIclusigJapanLicensingOncologyOtsuka PharmaceuticalResearch

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

18-12-2014

The Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from…

AmgenAsia-PacificBiotechnologyDanDrit BiotechEli LillyMarkets & MarketingMelCancerVacOncologyVectibixXBiotechXilonix

Australia and New Zealand abandon plans to form joint regulator

Australia and New Zealand abandon plans to form joint regulator

20-11-2014

The Ministers for Health from Australia and New Zealand have confirmed they are to end efforts to establish…

Asia-PacificAustraliaNew ZealandRegulationTherapeutic Goods Administration

Ethical business practices promoted by Medicines Australia singled out in APEC Declaration

Ethical business practices promoted by Medicines Australia singled out in APEC Declaration

14-11-2014

Ethical business practices promoted by industry representative Medicines Australia in Asia Pacific are…

Asia-PacificAustraliaMedicines AustraliaPharmaceuticalRegulation

Physicians in South Korea and Taiwan expect good uptake of SGLT-2 inhibitors

Physicians in South Korea and Taiwan expect good uptake of SGLT-2 inhibitors

20-10-2014

Prescribers are enthusiastic about the emergence of SGLT2-2 inhibitors for type 2 diabetes, but payers…

AbasriaAsia-PacificDiabetesLantusPharmaceuticalResearch

1 to 9 of 1497 results

COMPANY SPOTLIGHT

Menarini

Back to top